Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report

Meier, Nuciforo, Coto-Llerena et al. report a rare case of a patient with hepatocellular carcinoma with neuroendocrine differentiation. The authors establish organoids that recapitulate the genetic features of the patient’s tumor and are used for ex vivo drug testing to guide therapy selection in th...

Full description

Bibliographic Details
Main Authors: Marie-Anne Meier, Sandro Nuciforo, Mairene Coto-Llerena, John Gallon, Matthias S. Matter, Caner Ercan, Jürg Vosbeck, Luigi M. Terracciano, Savas D. Soysal, Daniel Boll, Otto Kollmar, Raphaël Delaloye, Salvatore Piscuoglio, Markus H. Heim
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-022-00150-3
_version_ 1828335275426709504
author Marie-Anne Meier
Sandro Nuciforo
Mairene Coto-Llerena
John Gallon
Matthias S. Matter
Caner Ercan
Jürg Vosbeck
Luigi M. Terracciano
Savas D. Soysal
Daniel Boll
Otto Kollmar
Raphaël Delaloye
Salvatore Piscuoglio
Markus H. Heim
author_facet Marie-Anne Meier
Sandro Nuciforo
Mairene Coto-Llerena
John Gallon
Matthias S. Matter
Caner Ercan
Jürg Vosbeck
Luigi M. Terracciano
Savas D. Soysal
Daniel Boll
Otto Kollmar
Raphaël Delaloye
Salvatore Piscuoglio
Markus H. Heim
author_sort Marie-Anne Meier
collection DOAJ
description Meier, Nuciforo, Coto-Llerena et al. report a rare case of a patient with hepatocellular carcinoma with neuroendocrine differentiation. The authors establish organoids that recapitulate the genetic features of the patient’s tumor and are used for ex vivo drug testing to guide therapy selection in the patient.
first_indexed 2024-04-13T21:44:02Z
format Article
id doaj.art-092df1cdee254031870f4d0caaa0bd75
institution Directory Open Access Journal
issn 2730-664X
language English
last_indexed 2024-04-13T21:44:02Z
publishDate 2022-07-01
publisher Nature Portfolio
record_format Article
series Communications Medicine
spelling doaj.art-092df1cdee254031870f4d0caaa0bd752022-12-22T02:28:38ZengNature PortfolioCommunications Medicine2730-664X2022-07-01211810.1038/s43856-022-00150-3Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case reportMarie-Anne Meier0Sandro Nuciforo1Mairene Coto-Llerena2John Gallon3Matthias S. Matter4Caner Ercan5Jürg Vosbeck6Luigi M. Terracciano7Savas D. Soysal8Daniel Boll9Otto Kollmar10Raphaël Delaloye11Salvatore Piscuoglio12Markus H. Heim13Department of Biomedicine, University Hospital and University of BaselDepartment of Biomedicine, University Hospital and University of BaselDepartment of Biomedicine, University Hospital and University of BaselDepartment of Biomedicine, University Hospital and University of BaselInstitute of Medical Genetics and Pathology, University Hospital BaselInstitute of Medical Genetics and Pathology, University Hospital BaselInstitute of Medical Genetics and Pathology, University Hospital BaselDepartment of Anatomic Pathology, IRCCS Humanitas Research Hospital, RozzanoClarunis University Center for Gastrointestinal and Liver DiseasesRadiology and Nuclear Medicine, University Hospital BaselClarunis University Center for Gastrointestinal and Liver DiseasesDepartment of Oncology, University Hospital BaselDepartment of Biomedicine, University Hospital and University of BaselDepartment of Biomedicine, University Hospital and University of BaselMeier, Nuciforo, Coto-Llerena et al. report a rare case of a patient with hepatocellular carcinoma with neuroendocrine differentiation. The authors establish organoids that recapitulate the genetic features of the patient’s tumor and are used for ex vivo drug testing to guide therapy selection in the patient.https://doi.org/10.1038/s43856-022-00150-3
spellingShingle Marie-Anne Meier
Sandro Nuciforo
Mairene Coto-Llerena
John Gallon
Matthias S. Matter
Caner Ercan
Jürg Vosbeck
Luigi M. Terracciano
Savas D. Soysal
Daniel Boll
Otto Kollmar
Raphaël Delaloye
Salvatore Piscuoglio
Markus H. Heim
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
Communications Medicine
title Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
title_full Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
title_fullStr Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
title_full_unstemmed Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
title_short Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
title_sort patient derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation a case report
url https://doi.org/10.1038/s43856-022-00150-3
work_keys_str_mv AT marieannemeier patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT sandronuciforo patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT mairenecotollerena patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT johngallon patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT matthiassmatter patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT canerercan patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT jurgvosbeck patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT luigimterracciano patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT savasdsoysal patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT danielboll patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT ottokollmar patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT raphaeldelaloye patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT salvatorepiscuoglio patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport
AT markushheim patientderivedtumororganoidsforpersonalizedmedicineinapatientwithrarehepatocellularcarcinomawithneuroendocrinedifferentiationacasereport